Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
EUDA Stock Forecast 2026-2027
$13.76
Current Price
$34.32M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to EUDA Price Targets
+299.7%
To High Target of $55.00
+299.7%
To Median Target of $55.00
+299.7%
To Low Target of $55.00
EUDA Price Momentum
-19.5%
1 Week Change
+104.8%
1 Month Change
-82.3%
1 Year Change
-70.2%
Year-to-Date Change
-84.0%
From 52W High of $86.00
+161.6%
From 52W Low of $5.26
📊 TOP ANALYST CALLS
Did EUDA Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Euda Health is one of their latest high-conviction picks.
Latest EUDA Stock Price Targets & Analyst Predictions
Based on our analysis of 1 Wall Street analyst, EUDA has a bullish consensus with a median price target of $55.00 (ranging from $55.00 to $55.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $13.76, the median forecast implies a 299.7% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
EUDA Analyst Ratings
1
Buy
0
Hold
0
Sell
EUDA Price Target Range
Low
$55.00
Average
$55.00
High
$55.00
Current: $13.76
Latest EUDA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for EUDA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 9, 2026 | Greenridge Global | William Gregozeski | Buy | Maintains | $2.75 |
Euda Health Holdings Limited (EUDA) Competitors
The following stocks are similar to Euda Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
EUDA
Euda Health
mkt cap
34.32M
Euda Health Holdings Limited (EUDA) Financial Data
Euda Health Holdings Limited has a market capitalization of $34.32M with a P/E ratio of 30.0x. The company generates $6.82M in trailing twelve-month revenue with a -40.7% profit margin.
Revenue growth is +78.9% quarter-over-quarter, while maintaining an operating margin of -34.8% and return on equity of +65.0%.
Valuation Metrics
Market Cap
$34.32M
Enterprise Value
$28.06M
P/E Ratio
30.0x
PEG Ratio
8.6x
Price/Sales
5.0x
Growth & Margins
Revenue Growth (YoY)
+78.9%
Gross Margin
+26.9%
Operating Margin
-34.8%
Net Margin
-40.7%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+1.3%
Current Ratio
0.2x
Debt/Equity
-0.6x
ROE
+65.0%
ROA
-89.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Euda Health Holdings Limited (EUDA) Business Model
About Euda Health Holdings Limited
What They Do
Provides non-invasive healthcare and property management services.
Business Model
Euda Health Holdings Limited generates revenue through two main segments: medical services and property management. The healthcare division focuses on specialty care and wellness solutions, including advanced therapies and membership programs, while the property management segment oversees various real estate properties, offering management and security services.
Additional Information
The company operates in Singapore, Malaysia, and China, and is listed on NASDAQ. Euda aims to be a leader in health technology, emphasizing longevity and accessibility of treatments, and maintains a diversified revenue stream from both healthcare and real estate sectors.
Company Information
Sector
Real Estate
Industry
Real Estate Services
Employees
117
CEO
Mr. Alfred Lim
Country
Singapore
IPO Year
2021
Website
eudahealth.comEuda Health Holdings Limited (EUDA) Latest News & Analysis
Latest News
Quick Summary
EUDA Health Holdings (NASDAQ: EUDA) announced that Shenzhen Inno Immune Co., Ltd. has received approval under the 2025 Shenzhen Key Industry R&D Program, enhancing its cellular therapy development in China.
Why It Matters
EUDA's partnership with Shenzhen Inno, backed by government approval, enhances growth prospects in the lucrative Asian healthcare market, potentially boosting investor confidence and stock value.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
EUDA Health Holdings Limited will execute a 1-for-20 reverse stock split effective March 23, 2026. Shares will continue trading under the symbol "EUDA" on Nasdaq.
Why It Matters
A 1-for-20 reverse stock split indicates a strategic move to boost share price and attract institutional investors, impacting liquidity and overall market perception of EUDA.
Source: GlobeNewsWire
Market Sentiment:
Neutral
EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant
2 months ago
Quick Summary
EUDA Health Holdings Limited (NASDAQ: EUDA) has fully repurchased and canceled a warrant issued to Streeterville Capital, LLC, as part of its operations in Singapore, Malaysia, and China.
Why It Matters
The repurchase and cancellation of the warrant by EUDA Health Holdings signals financial strength and potential stock price stability, which may enhance investor confidence and market perception.
Source: GlobeNewsWire
Market Sentiment:
Neutral
EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform
3 months ago
Quick Summary
EUDA Health Holdings (NASDAQ: EUDA) announced a convertible loan agreement with Shenzhen Inno Immune, aimed at advancing autologous cellular therapeutics in China.
Why It Matters
EUDA's convertible loan agreement with Shenzhen Inno expands its investment in innovative healthcare, potentially enhancing growth prospects and market position in Asia's healthcare sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
EUDA Health Holdings Limited (NASDAQ: EUDA) has amended its warrant agreement with Streeterville Capital, LLC, enhancing its financial arrangements. The company is focused on non-invasive healthcare in Asia.
Why It Matters
The amendment to the warrant agreement may affect EUDA's capital structure and financing options, potentially impacting its stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
EUDA Health Holdings Limited (NASDAQ: EUDA) has launched a stem cell extraction and storage platform in China, partnering with Shenzhen Inno Immune and Wuhan Kaien Hospital to enhance its healthcare services.
Why It Matters
EUDA's launch of a stem cell platform in China enhances its market position and growth potential, signaling a strategic expansion that may drive revenue and investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About EUDA Stock
What is Euda Health Holdings Limited's (EUDA) stock forecast for 2026?
Based on our analysis of 1 Wall Street analysts, Euda Health Holdings Limited (EUDA) has a median price target of $55.00. The highest price target is $55.00 and the lowest is $55.00.
Is EUDA stock a good investment in 2026?
According to current analyst ratings, EUDA has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $13.76. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for EUDA stock?
Wall Street analysts predict EUDA stock could reach $55.00 in the next 12 months. This represents a 299.7% increase from the current price of $13.76. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Euda Health Holdings Limited's business model?
Euda Health Holdings Limited generates revenue through two main segments: medical services and property management. The healthcare division focuses on specialty care and wellness solutions, including advanced therapies and membership programs, while the property management segment oversees various real estate properties, offering management and security services.
What is the highest forecasted price for EUDA Euda Health Holdings Limited?
The highest price target for EUDA is $55.00 from at , which represents a 299.7% increase from the current price of $13.76.
What is the lowest forecasted price for EUDA Euda Health Holdings Limited?
The lowest price target for EUDA is $55.00 from at , which represents a 299.7% increase from the current price of $13.76.
What is the overall EUDA consensus from analysts for Euda Health Holdings Limited?
The overall analyst consensus for EUDA is bullish. Out of 1 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $55.00.
How accurate are EUDA stock price projections?
Stock price projections, including those for Euda Health Holdings Limited, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 11, 2026 11:03 AM UTC